Orelabrutinib Combined With Zuberitamab in the Initial Treatment of MZL
Orelabrutinib Combined With Zuberitamab in the Initial Treatment of MZL
Recruiting · NCT06985472 · Registry updated 2025-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Orelabrutinib Combined With Zuberitamab in the Initial Treatment of MZL | BTKi; CD20; Initial MZL; Untreated MZL | Recruiting | Phase 2 | 2025-05-22 | NCT06985472 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Li Zhiming | 3 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sun Yat-sen University Cancer Center | Guangzhou | China | 315 |
| Sun Yat-sen University Cancer Center | Guangzhou | China | 1 |